SGMO Financial Facts
Collaboration agreements: 2.73MGeneral and administrative: 5.02M
See Full Income Statement
Total liabilities and stockholders' equity: 164.98M
Deferred revenues: 4.71M
See Full Balance Sheet
Sangamo Biosciences Inc. (SGMO) Earnings
|
Expand Research on SGMO
| Next EPS Date | 5/1/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -48.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/1/24 | Q124 | N/A | -$0.19 | N/A | N/A | $6.84M | N/A | N/A | N/A | ||
| 2/22/24 | Q423 | N/A | -$0.26 | N/A | N/A | $8.11M | N/A | N/A | N/A | ||
| 2/26/24 | Q423 | N/A | -$0.26 | N/A | N/A | $8.11M | N/A | N/A | N/A | ||
| 3/13/24 | Q423 | -$0.34 | -$0.26 | -$0.08 | $2.04M | $8.11M | N/A |  | | Details | |
| 11/1/23 | Q323 | -$0.59 | -$0.32 | -$0.27 | $9.39M | $9.36M | N/A | | | Details | |
| 8/8/23 | Q223 | -$0.66 | -$0.35 | -$0.31 | $6.84M | $13.26M | N/A | | | Details | |
4/26/23  |
Q123 | N/A | -$0.32 | N/A | N/A | $24.19M | N/A | N/A | N/A | ||
| 2/22/23 | Q422 | -$0.32 | -$0.36 | +$0.04 | $27.23M | $26.86M | N/A | | | Details |
